We then conducted similar experiments in vivo using xenograft models and observed that erastin specifically and significantly attenuated the development of lung cancer with the ELF3 overexpression and the PTEN-deficient background (Fig. 6I–L). This evidence concerns the gene ELF3 and lung cancer.